A Study of a Single Dose of ASP3291 in Subjects With Ulcerative Colitis

NCT01320332 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: ASP3291
DRUG: Placebo

Sponsor

Telsar Pharma Inc.